IL279221A - Use of halogen compounds for the treatment and prevention of tissue damage and syndrome after intensive care - Google Patents
Use of halogen compounds for the treatment and prevention of tissue damage and syndrome after intensive careInfo
- Publication number
- IL279221A IL279221A IL279221A IL27922120A IL279221A IL 279221 A IL279221 A IL 279221A IL 279221 A IL279221 A IL 279221A IL 27922120 A IL27922120 A IL 27922120A IL 279221 A IL279221 A IL 279221A
- Authority
- IL
- Israel
- Prior art keywords
- prevention
- post
- treatment
- intensive care
- tissue injury
- Prior art date
Links
- 150000002366 halogen compounds Chemical class 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- 208000037816 tissue injury Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862682574P | 2018-06-08 | 2018-06-08 | |
| US201862730927P | 2018-09-13 | 2018-09-13 | |
| US201862730945P | 2018-09-13 | 2018-09-13 | |
| PCT/US2019/036154 WO2019237065A1 (en) | 2018-06-08 | 2019-06-07 | Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL279221A true IL279221A (en) | 2021-01-31 |
Family
ID=68770655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL279221A IL279221A (en) | 2018-06-08 | 2020-12-06 | Use of halogen compounds for the treatment and prevention of tissue damage and syndrome after intensive care |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210252047A1 (enExample) |
| EP (1) | EP3801565A4 (enExample) |
| JP (1) | JP2021527130A (enExample) |
| KR (1) | KR20210018898A (enExample) |
| CN (1) | CN112469422A (enExample) |
| AU (1) | AU2019282820A1 (enExample) |
| CA (1) | CA3102792A1 (enExample) |
| IL (1) | IL279221A (enExample) |
| MX (1) | MX2020013306A (enExample) |
| WO (1) | WO2019237065A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3104939T3 (pl) | 2014-02-10 | 2024-09-30 | Fred Hutchinson Cancer Center | Leczenie jodkiem sodu zawału serca i urazu niedokrwiennego |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248335B1 (en) * | 1997-10-29 | 2001-06-19 | Symbollon Corporation | Stabilized oral pharmaceutical composition containing iodide and iodate and method |
| CZ295765B6 (cs) * | 1998-07-29 | 2005-10-12 | Apa - Praha, S.R.O. | Léčebný přípravek s virucidním účinkem |
| GB0525504D0 (en) * | 2005-12-14 | 2006-01-25 | Bristol Myers Squibb Co | Antimicrobial composition |
| PL3104939T3 (pl) * | 2014-02-10 | 2024-09-30 | Fred Hutchinson Cancer Center | Leczenie jodkiem sodu zawału serca i urazu niedokrwiennego |
-
2019
- 2019-06-07 EP EP19814153.3A patent/EP3801565A4/en not_active Withdrawn
- 2019-06-07 CN CN201980049776.3A patent/CN112469422A/zh active Pending
- 2019-06-07 JP JP2021518059A patent/JP2021527130A/ja active Pending
- 2019-06-07 MX MX2020013306A patent/MX2020013306A/es unknown
- 2019-06-07 CA CA3102792A patent/CA3102792A1/en active Pending
- 2019-06-07 AU AU2019282820A patent/AU2019282820A1/en not_active Abandoned
- 2019-06-07 WO PCT/US2019/036154 patent/WO2019237065A1/en not_active Ceased
- 2019-06-07 US US16/972,718 patent/US20210252047A1/en not_active Abandoned
- 2019-06-07 KR KR1020217000098A patent/KR20210018898A/ko not_active Ceased
-
2020
- 2020-12-06 IL IL279221A patent/IL279221A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021527130A (ja) | 2021-10-11 |
| KR20210018898A (ko) | 2021-02-18 |
| EP3801565A1 (en) | 2021-04-14 |
| AU2019282820A1 (en) | 2021-01-21 |
| WO2019237065A1 (en) | 2019-12-12 |
| CA3102792A1 (en) | 2019-12-12 |
| MX2020013306A (es) | 2021-05-12 |
| EP3801565A4 (en) | 2022-04-06 |
| US20210252047A1 (en) | 2021-08-19 |
| CN112469422A (zh) | 2021-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276398A (en) | Combined treatment for mastocytosis | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| SI3672954T1 (sl) | Spojine, njihove soli in njihova uporaba za zdravljenje bolezni | |
| IL272097A (en) | Compounds for the prevention and treatment of medical disorders and their uses | |
| IL274578A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| ZA202103977B (en) | Compounds and their use for the treatment of alpha1-antitrypsin deficiency | |
| IL282904A (en) | Therapeutic microbiota for the treatment and/or prevention of dysbiosis | |
| IL269083A (en) | Methods for preventing and treating heart disease | |
| IL272495A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| LT3697399T (lt) | Terapiniai agentai, skirti panaudoti gydant neramių kojų sindromą | |
| GB201918404D0 (en) | Compounds and their use for the treatment of aplha1-antitrypsin deficiency | |
| EP3750529A4 (en) | COMPOSITION FOR THE PREVENTION AND TREATMENT OF SPINAL MARSION LESIONS | |
| HK40050755A (en) | Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome | |
| IL287050A (en) | Compounds for the treatment of oncovirus induced cancer and methods of use thereof | |
| MX2020013306A (es) | Uso de compuestos de halogeno para el tratamiento y prevencion de lesiones tisulares y sindrome post-cuidados intensivos. | |
| IL284298A (en) | Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases | |
| IL276228A (en) | Compounds and preparations for the treatment of pain | |
| SG11202101788VA (en) | Agent for the treatment of skin wounds or burns | |
| IL310131A (en) | Prc-210 for use in the treatment of acute tissue injury | |
| GB2603379B (en) | Avocatin B for the treatment of diseases and conditions | |
| GB202111861D0 (en) | Materials for the treatment of medical conditions | |
| PL3813843T3 (pl) | Kompozycja do stosowania w zapobieganiu i/lub leczeniu chorób układu kostno-stawowego | |
| PT3829535T (pt) | Composições para prevenção e tratamento de afeções cutâneas | |
| LT3485894T (lt) | Vaistinių augalų derinys ir jų naudojimas miego sutrikimų gydymui ir (arba) prevencijai | |
| GB201820452D0 (en) | Compounds and their use for the treatment of alpha1-antitryspin deficiency |